Search Results - "Chapman-Rothe, N"

BRIDGE implementation science study to improve chronic spontaneous urticaria outcomes in Italy.

Authors: Asero R Iemoli E Chapman-Rothe N et al.

Source: The journal of allergy and clinical immunology. Global [J Allergy Clin Immunol Glob] 2026 Jan 20; Vol. 5 (3), pp. 100647. Date of Electronic Publication: 2026 Jan 20 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918453488706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-8293 (Electronic) Linking ISSN: 27728293 NLM ISO Abbreviation: J Allergy Clin Immunol Glob Subsets: PubMed not MEDLINE

Disease Control, Activity and Quality of Life in Chronic Spontaneous Urticaria: A Cross-Sectional Study from Kazakhstan.

Authors: Batyrbayeva, Aray Ispayeva, Zhanat Pashimov, Marat et al.

Source: Diagnostics (2075-4418). Mar2026, Vol. 16 Issue 5, p672. 11p.

Author Index.

Source: Experimental Dermatology. Nov2016 Supplement, Vol. 25, p52-56. 5p.

CRUSE^®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria.

Authors: Neisinger, Sophia Sousa Pinto, Bernardo Ramanauskaite, Aiste et al.

Source: Clinical & Translational Allergy. Jan2024, Vol. 14 Issue 1, p1-12. 12p.

Efficacy and safety of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis.

Authors: Cheng, Xueyun Zhou, Boyang Yu, Tianhang et al.

Source: Dermatologica Sinica. Oct-Dec2025, Vol. 43 Issue 4, p307-316. 10p.

Urticaria Voices: Real-World Treatment Patterns and Outcomes in Chronic Spontaneous Urticaria.

Authors: Bernstein, Jonathan A. Winders, Tonya A. McCarthy, Jessica et al.

Source: Dermatology & Therapy. Aug2025, Vol. 15 Issue 8, p2201-2215. 15p.

Effect of age on omalizumab response in chronic urticaria: a retrospective comparison between adult and geriatric populations.

Authors: Kolak S Çölkesen F Gerek ME et al.

Source: Allergologia et immunopathologia [Allergol Immunopathol (Madr)] 2026 May 01; Vol. 54 (3), pp. 1-8. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026).

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Codon Publications Country of Publication: Singapore NLM ID: 0370073 Publication Model: eCollection Cited Medium: Internet ISSN: 1578-1267 (Electronic) Linking ISSN: 03010546 NLM ISO Abbreviation: Allergol Immunopathol (Madr) Subsets: MEDLINE

Detection of metabolic adaptation in a triple-negative breast cancer animal model with [¹⁸F]choline-PET imaging as a surrogate for drug resistance.

Authors: Kohan, Andres A. Lupien, Mathieu Cescon, David et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Apr2024, Vol. 51 Issue 5, p1261-1267. 7p.

Biological and target synthetic treatments for chronic spontaneous urticaria: A systematic review and network meta‐analysis.

Authors: Zhao, Zuotao Zheng, Yaqi Song, Xiaoting et al.

Source: Clinical & Translational Allergy. May2025, Vol. 15 Issue 5, p1-14. 14p.

Temporal, Drug Dose, and Sample Size Trends in the Efficacy of Omalizumab for Chronic Spontaneous Urticaria: A Cumulative Meta‐Analysis.

Authors: Qin, Haiyan Xiao, Xianjun Qin, Di et al.

Source: Journal of Clinical Pharmacy & Therapeutics. 8/19/2024, Vol. 2024, p1-10. 10p.

Acceptance and perceived usefulness of digital health services in the management of chronic urticaria: a survey of patients and physicians.

Authors: Hindelang M Zink A Knitza J et al.

Source: BMC health services research [BMC Health Serv Res] 2025 Jul 02; Vol. 25 (1), pp. 894. Date of Electronic Publication: 2025 Jul 02.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE

Investigating proteogenomic divergence in patient-derived xenograft models of ovarian cancer.

Authors: Perez, Jesenia M. Duda, Jolene M. Ryu, Joohyun et al.

Source: Scientific Reports. 1/4/2025, Vol. 14 Issue 1, p1-18. 18p.

Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential.

Authors: Gilardini Montani, Maria Saveria Benedetti, Rossella Cirone, Mara

Source: Molecules. Dec2024, Vol. 29 Issue 24, p5817. 12p.

Efficacy and safety of Omalizumab in the treatment of CSU: a meta-analysis of a randomized controlled trial.

Authors: Zhang W Cao X Liu L

Source: Archives of dermatological research [Arch Dermatol Res] 2025 May 29; Vol. 317 (1), pp. 785. Date of Electronic Publication: 2025 May 29.

Publication Type: Journal Article; Meta-Analysis

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X (Electronic) Linking ISSN: 03403696 NLM ISO Abbreviation: Arch Dermatol Res Subsets: MEDLINE

EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.

Authors: Chen, Jianfeng Hong, Jing Han Huang, Yulin et al.

Source: Molecular Cancer. 5/20/2023, Vol. 22 Issue 1, p1-15. 15p.

The role of epigenetics in cancer: From pathways to the clinic.

Authors: Almalki, Abdulraheem A.¹ (AUTHOR) almalki@tu.edu.sa

Source: Journal of Family Medicine & Primary Care. Aug2025, Vol. 14 Issue 8, p3104-3114. 11p.

HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer.

Authors: Li, Xiao Zheng, Zhen Zhou, Wanzhen et al.

Source: Journal of Ovarian Research. 6/8/2024, Vol. 16 Issue 1, p1-14. 14p.

Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications.

Authors: Tang, Jinxin Zhuang, Yan Zhang, Yibo et al.

Source: Journal of Hematology & Oncology. 7/30/2025, Vol. 18 Issue 1, p1-35. 35p.

Experiences of omalizumab treatment in peritoneal dialysis and kidney and liver transplantation.

Authors: Bizzi E Samartin F Janu VP et al.

Source: Internal and emergency medicine [Intern Emerg Med] 2026 Jan; Vol. 21 (1), pp. 185-186. Date of Electronic Publication: 2025 Nov 18.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Italy NLM ID: 101263418 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1970-9366 (Electronic) Linking ISSN: 18280447 NLM ISO Abbreviation: Intern Emerg Med Subsets: MEDLINE; In Process

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.

Authors: Casale, Thomas B. Gimenez-Arnau, Ana Maria Bernstein, Jonathan A. et al.

Source: Dermatology & Therapy. Nov2023, Vol. 13 Issue 11, p2573-2588. 16p.